Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer

Oncology

Volumn 68, Issue 2-3, 2005, Pages 246-255

  Storojeva, Iana ^a   Boulay, Jean Louis ^a   Ballabeni, Pierluigi ^a   Buess, Martin ^a   Terracciano, Luigi ^a   Laffer, Urban ^b   Mild, Gabriele ^a   Herrmann, Richard ^a   Rochlitz, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Adjuvant chemotherapy; Loss of heterozygosity; Predictive prognostic factors; Randomized study

Indexed keywords

CADHERIN 7; DNAX ACCESSORY MOLECULE 1; FLUOROURACIL; SUPPRESSOR OF CYTOKINE SIGNALING 6; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CADHERIN; CD226 ANTIGEN; PROTEIN; SOCS6 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CHROMOSOME 18Q; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; AGED; CHROMOSOME 18; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SWITZERLAND;

AGED; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CADHERINS; CHROMOSOMES, HUMAN, PAIR 18; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINS; RANDOMIZED CONTROLLED TRIALS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SWITZERLAND;

EID: 23844439018     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086781     Document Type: Article

References (43)

1. Jen J, Kim H, Piantadosi S, et al: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-221.
2. Cho KR, Fearon ER:DCC: Linking tumor suppressor genes and altered cell surface interactions in cancer? Curr Opin Genet Dev 1995;5:72-78.
3. Fabre M, Martin M, Ulloa F, et al: In vitro analysis of the role of DCC in mucus-secreting intestinal differentiation. Int J Cancer 1999;81:799-807.
4. Gotley DC, Reeder JA, Fawcett J, et al: The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 1996;13:787-795.
5. Carethers JM, Hawn MT, Greenson JK, et al: Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 1998;114:1188-1195.
6. Thiagalingam S, Lengauer C, Leach FS, et al: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996;13:343-346.
7. Boulay JL, Mild G, Lowy A, et al: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 2002;87:630-634.
8. Boulay JL, Mild G, Lowy A, et al: SMAD7 is a prognostic marker in patients with colorectal cancer. Int J Cancer 2003;104:446-449.
9. Eppert K, Scherer SW, Ozcelik H, et al: MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996;86:543-552.
10. Fink SP, Swinler SE, Lutterbaugh JD, et al: Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res 2001;61:256-260.
11. Hayashi H, Abdollah S, Qiu Y, et al: The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling. Cell 1997;89:1165-1173.
12. Lallemand F, Mazars A, Prunier C, et al: Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 2001;20:879-884.
13. Mazars A, Lallemand F, Prunier C, et al: Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 2001;276:36797-36803.
14. Cohn KH, Ornstein DL, Wang F, et al: The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study. Cancer 1997;79:233-244.
15. Laurent-Puig P, Olschwang S, Delattre O, et al: Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992;102:1136-1141.
16. Lindforss U, Fredholm H, Papadogiannakis N, et al: Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 2000;88:2661-2667.
17. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al: Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998;16:427-433.
18. Martinez-Lopez E, Abad A, Font A, et al: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998;114:1180-1187.
19. Watanabe T, Wu TT, Catalano PJ, et al: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-1206.
20. Jernvall P, Makinen MJ, Karttunen TJ, et al: Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer 1999;79:903-908.
21. Lanza G, Matteuzzi M, Gafa R, et al: Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 1998;79:390-395.
22. Halling KC, French AJ, McDonnell SK, et al: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999;91:1295-1303.
23. Shimoyama Y, Tsujimoto G, Kitajima M, et al: Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J 2000;349:159-167.
24. Asgeirsson KS, Jiqm JG, Tryggvad inverted question markottir L, et al: Altered expression of E-cadherin in breast cancer. Patterns, mechanisms and clinical significance. Eur J Cancer 2000;36:1098-1106.
25. Oka H, Shiozaki H, Kobayashi K, et al: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-1701.
26. Nigam AK, Savage FJ, Boulos PB, et al: Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993;68:507-514.
27. Dorudi S, Hanby AM, Poulsom R, et al: Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 1995;71:614-616.
28. Shibuya A, Campbell D, Hannum C, et al: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4:573-581.
29. Yasukawa H, Sasaki A, Yoshimura A: Negative regulation of cytokine signaling pathways. Ann Rev Immunol 2000;18:143-164.
30. Yoshikawa H, Matsubara K, Qian GS, et al: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001;28:29-35.
31. Laffer U: Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK). Lancet 1995;345:349-353.
32. Bieche I, Olivi M, Champeme MH, et al: Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer. Int J Cancer 1998;78:661-666.
33. De Preter K, Speleman F, Combaret V, et al: Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002;15:159-166.
34. Specht K, Richter T, Muller U, et al: Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001;158:419-429.
35. Klein JP MM: Survival Analysis. New York, Springer Verlag, 1997.
36. Agresti A: Categorical Data Analysis, ed 2. New Jersey, Wiliey Interscience, Hoboken, 2002.
37. Vleminckx K, Vakaet L Jr, Mareel M, et al: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119.
38. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996;2:776-782.
39. Lee SW, Reimer CL, Campbell DB, et al: H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 1998;19:1157-1159.
40. Shimazui T, Giroldi LA, Bringuier PP, et al: Complex cadherin expression in renal cell carcinoma. Cancer Res 1996;56:3234-3237.
41. Adlard JW, Richman SD, Seymour MT, et al: Prediction of the response of colorectal cancer to systemic therapy. Lancet Oncol 2002;3:75-82.
42. Shibuya A, Lanier LL, Phillips JH: Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol 1998;161:1671-1676.
43. Thiagalingam S, Laken S, Willson JK, et al: Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci USA 2001;98:2698-2702.